Partnership opportunities
Collaboration is at the heart of advancing pediatric rare disease clinical trials. RareKids-CAN brings together industry, biotech, clinical trial sites, patient organizations, research networks, international collaborators, to share expertise, strengthen research capacity, and accelerate the development and delivery of innovative therapies for children with rare diseases in Canada.
Industry
Partner with RareKids-CAN to efficiently navigate Canada’s pediatric rare disease clinical trial landscape. Through our national network, we connect industry partners with investigators, clinical trial sites, patient partners, and regulatory expertise to support successful trial planning and delivery.
Clinical Trial Unit (CTU) sites
Partner with us to strengthen pediatric rare disease clinical trial capacity across Canada. We work with Clinical Trial Units to expand trial opportunities, share expertise, streamline collaboration, and connect sites with national research initiatives and industry sponsored trials.
International collaborations
Join a growing network of international partners committed to advancing pediatric rare disease clinical trials. Together, we facilitate knowledge exchange, connect expertise, and create opportunities for global collaboration to improve trial access and outcomes for children with rare diseases.
Research networks
Collaborate with us to accelerate pediatric rare disease clinical research in Canada. We partner with research networks to share expertise, align resources, foster multidisciplinary collaborations, and advance innovative clinical trial opportunities across Canada.
Patient organizations
Partner with us to ensure the patient voice is embedded throughout the clinical trial journey. We collaborate with patient organizations to improve trial awareness, inform study design, and connect families with research opportunities that matter to their communities.